Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 144:拟议出售证券
Mineralys Therapeutics | 8-K:重大事件
Mineralys Therapeutics | 4:持股变动声明-高管 Congleton Jon
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 4:持股变动声明-高管 Levy Adam Scott
Mineralys Therapeutics | 144:拟议出售证券
Mineralys Therapeutics | 144:拟议出售证券
Mineralys Therapeutics | 8-K:重大事件
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 10-Q:2024财年二季报
Mineralys Therapeutics | 8-K:Mineralys Therapeutics公布2024年第二季度财务业绩并提供公司最新情况
Mineralys Therapeutics | 4:持股变动声明-董事 Slingsby Brian Taylor
Mineralys Therapeutics | 144:拟议出售证券
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 144:拟议出售证券
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
Mineralys Therapeutics | 4:持股变动声明-高管 Levy Adam Scott
Mineralys Therapeutics | 4:持股变动声明-高管 Congleton Jon
暂无数据
暂无数据